and mortality for American Indians and Alaska Natives (AI/ANs), but misclassification of race causes underestimates of disease burden.
populations from 1995 to 2004, there was no significant change in AI/AN rates. 2 It has been demonstrated that CRC mortality varies significantly between AI/AN populations living in different regions of the US, with a >3-fold difference between the Southwest and Alaska. 1 AI/AN males and females, as a group, reportedly have CRC incidence rates that are lower than the US average; however, summary measures may miss important rate heterogeneity between AI/AN populations. 4 Accurate determination of cancer burden is a critical first step for addressing health disparities. Race misclassification in medical records and on death certificates makes determining cancer rates for AI/AN populations difficult. 5, 6 Forthcoming data from the National Longitudinal Mortality Survey correlating self-identified race from Current Population Surveys with information on death certificates indicate that AI/ANs are classified as another race 44 .8% of the time. 7 Such misclassification results in underestimates of both cancer incidence and mortality. [8] [9] [10] [11] The objective of the current analysis was to compare regional CRC incidence rates by age, stage at diagnosis, and the colonic location of CRC tumors between AI/AN and non-Hispanic white (NHW) populations living in the same counties. This study is part of a larger effort linking the Centers for Disease Control and Prevention (CDC) National Program of Cancer Registries (NPCR) database; the National Cancer Institute (NCI) Surveillance, Epidemiology, and End Result (SEER) database; and the Indian Health Service (IHS) database to minimize the effects of race misclassification on estimates of cancer incidence.
MATERIALS AND METHODS

Data Sources
A more comprehensive description of the analytical methods used for this and other articles in this supplement of Cancer is published separately. 12 We analyzed population-based cancer incidence data from the NPCR and from the SEER Program. 13, 14 If data from central cancer registries that provided permission for their use met quality criteria, then they were included in the analysis (see footnote to Table 1 for a list of registries). Population estimates from the US Bureau of the Census, modified by the CDC and the NCI, were used as denominators in the rate calculations. 15 , 16 We included incident cases of invasive CRC as detailed elsewhere. 17 were combined for this analysis, because the differences observed in comparative studies of the 2 systems were minimal. 18, 19 Tumor histology was categorized as proposed by Berg 20 and modified by Stewart et al. 21 To reduce the misclassification of AI/AN cases as other races, all cancer case records from NPCR and SEER registries were linked with IHS patient registration databases using a probabilistic linkage software developed by the CDC. 14 The IHS database identifies all individuals who have ever accessed IHS services. In addition, we focused on those AI/AN and NHW populations that were living in counties where individuals were eligible for IHS contract care services, called Contract Health Service Delivery Areas (CHSDAs).
The 6 IHS regions used in this analysis (Alaska, Pacific Coast, Northern Plains, Southern Plains, Southwest, and East) and their constituent CHSDA counties are shown in Figure 1 . CHSDA counties, in general, contain federally recognized tribal lands or are adjacent to tribal lands. AI/AN males and females must live within CHSDA boundaries and be members of a federally recognized tribe to be eligible for health services that are not available at IHS or tribal health facilities. The proportions of the population that are AI/AN relative to the total population are higher in CHSDA counties than in non-CHSDA counties, and there is inherently less misclassification of race in medical and death records. 7 Overall, 56% of AI/ANs live in CHSDA counties; however, this varies by region (Alaska, 100%; East, 13.1%; Northern Plains, 59%; Southern Plains, 64.1%; Pacific Coast, 55.6%; and Southwest, 87.5%).
Statistical Analyses
Two sets of statistics are provided for AI/AN and NHW cancer cases: 1) data from all counties in the respective regions (referred to as 'All Counties'), and 2) data from all counties designated as CHSDA (referred to as 'CHSDA counties'). The results described below refer to individuals who reside in CHSDA counties unless otherwise noted.
The age groups for analysis (<40 years, 40-49 years, 50-64 years, and 65 years) were selected with consideration of recommendations that average-risk individuals begin CRC screening at age 50 years and that screening colonoscopy coverage by Medicare, which is available to most US citizens, begin at age 65 years. 22, 23 Anatomic subsites of incident cancers For all AI/AN and NHW populations, cancer incidence rates were expressed per 100,000 persons per year and were age-adjusted by 19 age groups (<1 year, 1-4 years, 5-9 years, . . . , 80-84 years, 85 years) to the 2000 US standard population using the direct method. 13 Percent distributions for histology, stage, and anatomic subsite also were age-adjusted to the 2000 population. Ninety-five percent confidence intervals (CIs) for age-adjusted rates were calculated using the modification of Tiwari et al. 24 Rate ratios (RRs) were calculated as the age-adjusted incidence rate for the AI/AN population of interest divided by the age-adjusted incidence rate for the same-area NHW population. The cancer incidence data were analyzed using SEER*Stat software, version 6.3.6.
25
RESULTS
Over the 6-year study period (1999 to 2004), there were 3316 cases of invasive CRC diagnosed in the All-Counties AI/AN population and 681,801 cases diagnosed in the NHW population. Of these, 95.3% of AI/AN cases and 96.5% of NHW cases were confirmed microscopically. Microscopically confirmed cancers among AI/AN cases were 94.7% adenocarcinomas, 3% other specified carcinomas, 0.9% carcinomas not otherwise specified (NOS), 0.3% epidermoid carcinomas, and 1.1% other histologic types. The corresponding percentages among NHW cases were 95.7%, 2%, 1.2%, 0.4%, and 0.7%, respectively. Signet ring cell carcinomas accounted for 0.9% of microscopically confirmed CRC cases among AI/ANs and 1.1% among NHWs.
Among AI/ANs with CRC, 79% (2621 individuals) were residents of CHSDA counties compared with 21% (143,160) of NHWs ( Table 1 ). The age-adjusted CRC incidence rate among AI/ANs was 46.3 in CHSDA counties and 33.9 in All Counties. CHSDA AI/ANs had a 9% lower overall incidence rate of CRC compared with the rate among CHSDA NHWs (RR, 0.91; 95% CI, 0.87-0.95). In contrast, the All-County AI/AN incidence rate was 36% lower than the All County NHW incidence rate. The remaining results presented below are limited to residents of CHSDA counties, because All-County data are likely underestimates because of misclassification of race not corrected by our IHS linkage strategy.
Regional CHSDA incidence rates were significantly higher in AI/ANs than NHWs in Alaska, the Northern Plains, and the Southern Plains, whereas the rates were significantly lower in the Pacific Coast, East, and Southwest (Table 1 ). There was a nearly 5-fold regional variation in incidence among AI/AN populations (from 21.0 in the Southwest to 102.6 in Alaska) compared with modest geographic variation among NHW populations (from 46.8 in the Southwest to 55.2 in the East). The pattern of regional variation in incidence was apparent for both AI/AN males and females. CRC incidence rates were consistently higher among males with the exception of Alaska and the East region. In Alaska, the AI/AN female incidence rate of 106.2 was 2.6 times higher than that of NHW Alaskan females and the highest of any group in the analysis.
Stratifying by age (Tables 2 and 3 ) and among those living in CHSDA counties, AI/AN populations had comparable or slightly higher rates of CRC than NHW populations (<40 years: RR, 1.25; 40-49 years: RR, 1.05; 50-64 years: RR, 1.05). One exception was that the overall CRC rate was significantly lower in AI/ANs aged 65 years (RR, 0.84). Important regional differences also were observed within and between age strata: 9.5% of CRC cases occurred among AI/AN males and females aged <50 years (the age for initiating CRC screening among average-risk individuals) compared with 7.9% of CRC cases among NHW individuals. Dramatically higher rates of CRC were from Alaska were the least likely to have late-stage CRC at diagnosis, whereas Eastern males and Northern and Southern Plains females were the most likely.
Excluding the appendix, NOS subsites, and overlapping lesions, 36% of CRCs among AI/ANs were located in the proximal portion (cecum to splenic flexure) of the colon compared with 45.3% of CRCs among NHW males and females from 1999 through 2004. The overall RR of proximal to distal (splenic flexure through rectum) disease was lower among AI/ANs than among NHWs, indicating a lower propensity toward proximal disease; the exceptions were for both sexes in the East and among females in Alaska, the Pacific Coast, and the Southwest, where AI/AN rates of proximal and distal CRC were not statistically different (Table 5 ). Females were more likely than males to be diagnosed with proximal disease among both AI/ANs and NHWs (40.6% and 50.7% among AI/AN and NHW females, respectively, compared with 31.3% and 40.4% among AI/AN and NHW males).
DISCUSSION
The objective of this study was to describe more accurately the incidence of CRC in AI/AN populations by linking NPCR and SEER cancer registry data with IHS records and then focusing on CHSDA counties where the misclassification of race was less pre- valent. During the study period, CRC was the third most commonly diagnosed cancer among CHSDA AI/AN males and females, accounting for 11.8% of all cancers. 26 Our most dramatic finding was the regional variation in CRC incidence, with an almost 5-fold difference observed between AI/AN populations in Alaska and the Southwest. Also important were differences in incidence, stage of diagnosis, and colonic subsite distribution between AI/AN and NHW populations. Because only 56% of AI/ANs live in CHSDA counties (15% in the East Region), caution should be exercised not to generalize our results to the entire AI/AN population.
Geographic, racial, and gender differences in both CRC incidence and the distribution of incident cancers by colonic subsite may provide insights into etiologic risk factors and are important for guiding CRC screening recommendations. Regional differences in CRC incidence are likely a function of the heterogeneity of AI/AN populations, which vary greatly in culture, diet, resources, environment, and, theoretically, even genetic risk. Regional data from the Behavioral Risk Factor Surveillance System (BRFSS) suggest that AI/AN males and females have a higher prevalence of known CRC risk factors, including diabetes, obesity, smoking, and binge alcohol consumption. 27 Except for smoking, however, regional variations of these risk factors do not appear to mirror regional differences in CRC incidence rates. Smoking rates during 1999 through 2003 for Southwest AI/ANs (20.4%) were less than 50% of those reported in the Northern Plains and Alaska (both 43.9%).
Regional differences in diet and environmental micronutrients also may modify CRC risk. 28, 29 For example, previous studies have suggested that solar irradiance and its role in vitamin D production may explain in part the North-South CRC incidence gradient observed in the general population. 30, 31 It also is believed that calcium intake decreases CRC risk, and calcium is plentiful in the ground water of the Navajo reservation. 32, 33 Other population differences that also may alter the risk of CRC include the dietary intake of animal fats, folate, and the consumption patterns of fresh produce. [34] [35] [36] [37] In several areas, AI/ANs appeared to be susceptible to CRC at younger ages than NHWs. During the study period, there were 40 cases of CRC in the Southern Plains that occurred in AI/ANs aged <40 years, a rate 66% higher than that for NHWs in this age group. Significantly higher rates of CRC also were observed among AI/ANs ages 40 to 49 years in Alaska and the Northern Plains. The onset of CRC in young populations should raise suspicion for the presence of hereditary CRC syndromes. Indeed, Navajo kindreds with hereditary nonpolyposis CRC syndrome have been followed for decades. 38 Further work is needed in these populations to elucidate CRC risk factors and to assess whether CRC screening recommendations should be modified to include younger individuals.
Regional differences in CRC screening also may affect incidence. It is believed that screening primarily is responsible for the declining rate of CRC in the general population while it also contributes to a shift toward earlier stages of disease at diagnosis. 22, 39 Flexible sigmoidoscopy screening also has been implicated in a temporal shift of incident CRCs from the distal colon and rectum to more proximal sites. [40] [41] [42] [43] Although BRFSS data suggest that AI/ANs have lower CRC fecal occult blood testing (FOBT) and endoscopic screening rates than NHWs (overall, 44.0% and 53.8%, respectively), 27 the true screening disparity may be far greater. Participation in the BRFSS requires individuals have a telephone and be willing to be interviewed. 44 For AI/ ANs, this tends to select those with more income, higher levels of education, and less traditional ways of life, all of which have been associated with higher rates of screening participation. 8, 45, 46 In addition, cultural factors, including a reluctance to trust outsiders, modesty, and hesitancy to discuss one's health, may bias BRFSS prevalence estimates further for AI/ANs.
Data from other sources suggest significant variation in screening rates between AI/ANs and NHWs. For example, a 2007 review of CRC screening compliance among patients who visited Alaska tribal health centers reported that 34.8% of individuals aged 50 years were current with U.S. Preventive Services Task Force CRC screening recommendations, although rates from individual tribal health facilities ranged from 5.5% to 60.8%. 47 This compares with a reported Alaska AI/AN BRFSS rate of 49.5%. 27 Although financial, institutional, geographic, and cultural barriers to CRC screening vary widely between communities, AI/ANs in the Southwest and Northern Plains are significantly less likely than the general population to have undergone CRC screening. 48, 49 Poverty, low education attainment, and insufficient health coverage are major challenges for AI/AN communities and also most likely contribute to lower screening rates. [50] [51] [52] The colonic subsite distribution of CRC has major relevance for the choice of methods used for screening. For example, prior reports have demonstrated that females in the US have a higher prevalence of adenomatous polyps and CRCs in the proximal colon than men, leading to conclusions that colonoscopy is a preferable CRC screening option for females. 42, 53 Our work also indicated that females had a greater propensity toward proximal CRC. NHW females had a near equal prevalence of proximal to distal cancers, whereas NHW males had proportionally fewer proximal cancers. Similarly, AI/ AN females had a higher proportion of proximal cancers than AI/AN men. However, as a population, AI/ ANs had proportionately more distal cancers (64%) than NHWs (55%). Factors other than gender that are believed to influence subsite distribution include smoking, physical activity, alcohol abuse, diabetes, nonsteroidal anti-inflammatory drug use, and dietary factors. 40, [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] A better understanding of the relative risks of these variables and CRC in AI/AN populations is needed.
Our analysis revealed that AI/ANs were diagnosed more commonly with later stage CRC than NHWs. Many factors influence the stage at which CRC is diagnosed. AI/AN communities face substantial barriers to the early detection and prevention of CRC. Limited availability of endoscopic services, provider time pressures, health systems that are geared and used primarily for acute and subacute care, and an underfunded health system are institutional barriers to screening for many AI/AN healthcare systems. In addition, cultural hesitance to access Western medicine for nonacute health problems, infrequent provider recommendations to get screened, insufficient health coverage, inability to afford Medicare or insurance copays, and transportation difficulties are factors commonly cited as cancer screening barriers by AI/AN individuals. 46, [64] [65] [66] Alaska, although it has the highest AI/AN population CRC rates, had the highest proportion of cases detected in early stages. Among IHS regions, Alaska has been the most proactive toward CRC screening. Since 2000, Alaska has increased its CRC screening rate by >50%. 47 Vanguard efforts have included the training and employment of a nurse practitioner who conducts screening colonoscopies in Anchorage and programs to train mid-level providers to conduct flexible sigmoidoscopies at regional health facilities. 67, 68 Innovation has been spurred by the CRC burden as well as by the necessary abandonment of guaiac-based FOBT because of a high prevalence of Helicobacter pylori-associated hemorrhagic gastritis. 69 The commitment of the Alaska Native Tribal Health Consortium to increasing endoscopic capacity, overcome cost and transportation barriers, and the implementation of screening promotion programs are having a positive impact on disease stage at diagnosis.
In our study, CRC incidence rates appeared to be much higher among AI/AN males and females living in CHSDA counties than in all counties. This difference is most likely because of higher rates of race misclassification in non-CHSDA areas that are not corrected by our linkage rather than true differences in incidence. In 2000, 64.1% of the AI/AN population lived outside of Census Bureau-defined 'American Indian areas,' and >31% were not considered part of the IHS population. 70, 71 Data on the health status of these mostly urban AI/AN populations are scarce and resources are fleeting, with only 1% of the annual IHS appropriation available to support 34 urban AI/AN clinics across the nation. More work to define and address the health of urban AI/AN populations clearly is needed.
For this study, linkages and geographic analyses were used to reduce the misclassification of race in AI/AN populations to more accurately describe CRC incidence. Clearly, there are significant regional differences in CRC rates among AI/AN males and females. Work to understand the reasons behind this 5-fold variation holds great promise for elucidating CRC risk factors, not only for AI/AN populations but for all populations. Our findings that AI/AN tend to be diagnosed with more advanced disease, coupled with the apparent success of Alaskan endoscopic screening programs in capturing earlier stage diagnoses, call for resources and diligence in approaching this disparity. Currently, approximately 1 in 18 Americans will be diagnosed with CRC in their lifetime. 72 The lifetime risk for AI/AN males and females in Alaska and the Northern and Southern Plains is higher. Although efforts aimed at modifying CRC risk factors are important, they are often a generational objective. Meanwhile, up to 90% of CRC can be prevented by screening and surveillance because of the efficacy of removing adenomatous polyps before they become cancers. 43, 73 Disparities in CRC incidence and stage at diagnosis are likely to persist until screening is made a priority for tribal health systems, the many barriers to screening are overcome, and AI/AN communities are engaged in culturally appropriate ways to participate.
